The UBS Global Healthcare Conference is underway in New York this week, and the stocks of several participating companies are on the move.

Here’s a breakdown of which stocks to watch.

AcelRx Pharmaceuticals Inc ACRX 10.19%

AcelRX announced on Tuesday that is has entered into a contract with the U.S. Department of Defense that is worth up to $17 million. Shares of the $145 million company were up about 8.0 percent following the news.

Affimed NV AFMD 1.48%

The market liked what it heard out of Affimed’s UBS presentation on Tuesday morning. Shares jumped about 4.0 percent during the talk.

Atara Biotherapeutics ATRA 3.97%

The market seems to be having the complete opposite reaction to shares of Atara, which have fallen as much as 8.0 percent on Tuesday following…

Read the rest of this article (and all my other articles) for free on Benzinga by clicking here

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!